ArticlePharmaceuticals (Basel, Switzerland)2022

Design, Synthesis, and Biological Evaluation of a Novel VEGFR-2 Inhibitor Based on a 1,2,5-Oxadiazole-2-Oxide Scaffold with MAPK Signaling Pathway Inhibition.

Mater H Mahnashi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.